Disposition of captopril in normal subjects.
The disposition of captopril, an angiotensin-converting enzyme inhibitor with antihypertensive properties, was studied in 10 normal male subjects after a single 100-mg tablet of 35S-labeled drug. Average absorption parameters for unchanged captopril in blood were Tmax 0.93 +/- 0.08 hr and Cmax 800 +/- 76 ng/ml. For total radioactivity in blood the values were Tmax 1.05 +/- 0.08 hr and Cmax 1,580 +/- 90 ng/ml (as captopril equivalents). Because of the curvilinearity of the semilogarithmic plots of blood concentrations of captopril:time, elimination half-life (t1/2) of unchanged drug could not be determined. At 1 hr unchanged captopril accounted for about 52% of total radioactivity in blood, and the dimeric disulfide metabolite of captopril accounted for about 10%. In the first 5 days after dosing, an average of about 68% of the radioactive dose was recovered in urine and 18% in feces. The distribution of radioactivity in the first 24-hr urine sample (66% of the dose) was 58% captopril (38% of dose), 2% captopril disulfide (1.5% of dose), and 40% unidentified polar metabolites (26% of dose).
D000042:Absorption; D000293:Adolescent; D000328:Adult; D002216:Captopril / Q000097:blood / Q000378:metabolism* / Q000652:urine; D004220:Disulfides / Q000097:blood / Q000652:urine; D005243:Feces / Q000032:analysis; D006207:Half-Life; D006801:Humans; D008297:Male; D011392:Proline / Q000031:analogs & derivatives*; D013997:Time Factors
D004220:Disulfides; D011392:Proline; D002216:Captopril